🇺🇸 FDA
Company

CERO

CERO THERAPEUTICS HOLDINGS, INC.

CERO biotech USA

Quick answer

CERO is a biotech company (CERO) headquartered in SOUTH SAN FRANCISCO, CA, USA with 1 tracked pipeline programs.

Pipeline (1)

project

CER-1236

AML

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12303551

Cellular immunotherapy compositions and uses thereof

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12291557

Chimeric TIM4 receptors and uses thereof

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11708423

Chimeric engulfment receptor molecules and methods of use

Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11697689

Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic

Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11655282

Chimeric engulfment receptor molecules

Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10675246

Orally administrable compositions comprising calcium

Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10307410

Mcl-1 modulating compounds for cancer treatment

Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10273307

Humanized anti-CD134 (OX40) antibodies and uses thereof

Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)